Back To Schedule
#317: Global Medical Device Development: Regulatory Concordance or Discordance?
Chair MA
DRA Policy Head of Medical Device and Combination Products, Novartis Pharmaceuticals Corporation
Mary Ann Smith is Regulatory Policy Director, Digital Medicine & Devices, with Novartis since 2009 focused on software as a medical device, technology applications and enabled clinical trials, combination products and regulatory strategy. Ms. Smith has regulatory experience at Nektar...
Read More →
Speakers NS
Special Advisor, International Programs Division, Health Canada
DIA
Associate Vice President, Regulatory Affairs - Devices, Sanofi US
Anthony Watson is the Head of Regulatory Affairs - Devices, for Sanofi, in Cambridge, Massachusetts. Before Sanofi, he was the Director of Regulatory Affairs, CMC, Combination Products at Biogen. Prior to Biogen, he was a Division Director responsible for drug delivery devices in...
Read More →
Wednesday June 29, 2016 10:30am - 11:45am EDT
103C
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA